Peking University Cancer Hospital & Institute: Liver Neoplasms trials
The registry lists 10 Liver Neoplasms studies with Peking University Cancer Hospital & Institute as lead sponsor. 3 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 3No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver MetastasisNot yet recruitingNCT07007728Phase 2
- The Role and Safety of Radiofrequency Ablation in Recurrent Liver Metastasis of Colorectal CancerNot yet recruitingNCT06609434Not applicable
- To Evaluate the Performance of HepaSphere Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy on Unresectable Colorectal Liver MetastasesNot yet recruitingNCT05889325
- Dynamic ctDNA Detection for Colorectal Cancer Liver MetastasesCompletedNCT06404593
- HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell CarcinomaCompletedNCT06184841Phase 1
- The Safety and Efficacy of HAIC+Tislelizumab+Regorafenib in Patients With Colorectal Liver MetastasesStatus unknownNCT05877001Phase 2
- Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line TherapyStatus unknownNCT05406206Phase 2
- To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency AblationStatus unknownNCT04417010
- The Effect of Percutaneous Radiofrequency Ablation of Feeding Arterial for Hepatocellular CarcinomaStatus unknownNCT03143140Not applicable
- A Trial on Contrast-enhanced Ultrasound Versus Conventional Ultrasound Guided Biopsy of Liver NeoplasmsStatus unknownNCT02413437Not applicable